{"schema_version":"1","generated_at":"2026-11-02T00:26:55.145Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/ashish-shah","json_url":"https://www.findmykol.com/kol/ashish-shah/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"ashish-shah","name":"Ashish Shah","credential":"DO","title":"Hematology and Medical Oncology physician (Advanced Care Oncology and Hematology)","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology"],"institution":"Advanced Care Oncology and Hematology","institution_url":"https://www.findmykol.com/institution/advanced-care-oncology-and-hematology","city":"Springfield","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1285820274"},"summary":"Ashish Shah is Hematology and Medical Oncology physician (Advanced Care Oncology and Hematology) at Advanced Care Oncology and Hematology. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.","overview":{"text":"Ashish Ashvin Shah, D.O., is Hematology and Medical Oncology physician (Advanced Care Oncology and Hematology). It also documents an investigator role on 6 registered clinical trials, industry payments reported by 73 companies.","bullets":["Top research focus: Glioma","6 registered trials on ClinicalTrials.gov","Open Payments reporting from 73 companies"],"generated_at":"2026-11-01"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Glioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Surgical Wound Infection","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Wounds and Injuries","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Ankle Injuries","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3}],"research_topics":["Glioma","Neuro-Oncology / Glioma","Astrocytoma"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Venclexta","generic":"Venetoclax","trials":0,"payments":208,"publications":0,"mentions":208},{"name":"Vyxeos","generic":"Cytarabine / daunorubicin","trials":0,"payments":52,"publications":0,"mentions":52},{"name":"Reblozyl","generic":"Luspatercept","trials":0,"payments":30,"publications":0,"mentions":30}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Abbvie Inc.","trials":0,"payments":221,"mentions":221},{"name":"Jazz Pharmaceuticals Inc.","trials":0,"payments":55,"mentions":55},{"name":"Pfizer Inc.","trials":0,"payments":43,"mentions":43}]}},"scholarship":{"h_index":0,"latest_activity_year":2025,"source":"works"},"trials":{"count":6,"shown":3,"withheld":3,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06504381","title":"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT06504381","trial_url":"https://www.findmykol.com/trial/NCT06504381"},{"nct":"NCT06428045","title":"STARLITE for Unresectable High-Grade Gliomas","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"University of Miami","source_url":"https://clinicaltrials.gov/study/NCT06428045","trial_url":"https://www.findmykol.com/trial/NCT06428045"},{"nct":"NCT06264388","title":"DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Ashish Shah","source_url":"https://clinicaltrials.gov/study/NCT06264388","trial_url":"https://www.findmykol.com/trial/NCT06264388"}],"source":"trials"},"payments":{"company_count":73,"program_years":{"first":2021,"last":2025},"rows_total":147,"shown":3,"withheld":144,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":59538.36,"payment_count":66,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285820274"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":14243.92,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285820274"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":11931.49,"payment_count":21,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285820274"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285820274","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":39.9,"classes_total":2,"classes":[{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":30.4,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":null},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":9.5,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":35.1,"classes_total":3,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":18.9,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":11},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":8.1,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":11}]},{"area":"Anti-infectives","share_pct":13.5,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":13.5,"drugs":[{"name":"Valacyclovir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":77.5,"facility_pct":22.5},"source":"medicare"},"funding":{"award_count":0,"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"R21CA282543","title":"A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma","fiscal_year":2024,"amount_usd":204520,"organization":"UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/R21CA282543"},{"project":"R21CA282543","title":"A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma","fiscal_year":2023,"amount_usd":179403,"organization":"UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/R21CA282543"},{"project":"F32HL009907","title":"RIGHT VENTRICULAR MECHANICS IN TRICUSPID REGURGITATION","fiscal_year":1998,"organization":"DUKE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/F32HL009907"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"DO, Philadelphia College of Osteopathic Medicine (medical school)","source_url":"https://atlantichealth.org/find-a-doctor/ashish-shah-1285820274","status":"verified","collected_at":"2026-11-01"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Member, American Society of Clinical Oncology","source_url":"https://www.atlantichealth.org/find-a-doctor/ashish-shah-1285820274","status":"provisional","collected_at":"2026-11-01"},{"value":"Member, American Society of Hematology","source_url":"https://www.atlantichealth.org/find-a-doctor/ashish-shah-1285820274","status":"provisional","collected_at":"2026-11-01"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Clinical assistant professor, University of South Florida (prior)","source_url":"https://atlantichealth.org/find-a-doctor/ashish-shah-1285820274","status":"provisional","collected_at":"2026-11-01"}]}},"similar":[{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"payments":144}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-01"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-01"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-01"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}